Breaking News

Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here

Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Close

Ocular Therapeutix Inc (OCUL)

Add to/Remove from Watchlist Add to Watchlist

3.06 -0.21 -6.55%

10:50:21 - Real-time Cboe. Currency in USD ( Disclaimer )

Type: Equity

Market: United States

ISIN: US67576A1007

CUSIP: 67576A100

Volume: 80,903
Bid/Ask: 0.00 / 0.00
Day's Range: 3.07 - 3.23

News
Analysis & Opinion

OCUL News

This page features the latest news about the Ocular Therapeutix Inc stock.

Ocular Therapeutix Tops Q1 EPS by 4c

Ocular Therapeutix Tops Q1 EPS by 4c By Investing.com - May 09, 2022

Ocular Therapeutix (NASDAQ:OCUL) reported Q1 EPS of ($0.22), $0.04 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $14.2...

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.21%

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.21% By Investing.com - Oct 22, 2021

Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Financials, Oil & Gas and Consumer Goods sectors led shares higher while losses in the Technology, Consumer Services...

Ocular Therapeutix Stock Tumbles After Eye Study Failure

Ocular Therapeutix Stock Tumbles After Eye Study Failure By Investing.com - Oct 22, 2021

By Sam Boughedda Investing.com — Shares of Ocular Therapeutix Inc (NASDAQ:OCUL) tumbled over 34% Friday after the failure of its Phase 2 clinical trial of OTX-CSI to treat dry eye disease. Ocular...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.71%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.71% By Investing.com - Apr 29, 2021

Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the Telecoms, Financials and Oil & Gas sectors led shares higher. At the close in NYSE, the Dow Jones Industrial...

Raymond James Stick to Their Buy Rating for Ocular Therapeutix

Raymond James Stick to Their Buy Rating for Ocular Therapeutix By Investing.com - Mar 12, 2021

Raymond James analyst Dane Leone maintained a Buy rating on Ocular Therapeutix (NASDAQ:OCUL) on Thursday, setting a price target of $25, which is approximately 23.09% above the present share price of...

H.C. Wainwright Sticks to Their Buy Rating for Ocular Therapeutix

H.C. Wainwright Sticks to Their Buy Rating for Ocular Therapeutix By Investing.com - May 11, 2020

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Ocular Therapeutix (NASDAQ:OCUL) on Monday, setting a price target of $10, which is approximately 67.50% above the present share price of...

Ocular Therapeutix beats by $0.08, misses on revenue

Ocular Therapeutix beats by $0.08, misses on revenue By Seeking Alpha - Mar 08, 2018

Ocular Therapeutix (NASDAQ:OCUL): Q4 EPS of -$0.44 beats by $0.08.Revenue of $0.49M (-3.9% Y/Y) misses by $0.03M.Press ReleaseNow read: Your Daily Pharma Scoop: Conatus Rallies, Ionis Data, Reata's...

Premarket Losers as of 9:05 am (1/25/2018)

Premarket Losers as of 9:05 am (1/25/2018) By Seeking Alpha - Jan 25, 2018

CFMS -33% on pricing stock offering at $1.50.OCUL -12% on announcing public offering of common stock.ACHV -8%.VUZI -8% on announcing registered direct offering.NWL -7% on announcing preliminary 2017...

Healthcare Gainers / Losers as of 11:00 am

Healthcare Gainers / Losers as of 11:00 am By Seeking Alpha - Nov 27, 2017

Gainers: AHPI +26%. MGCD +24%. CERC +21%. FCSC +16%. NEPT +9%.Losers: RIOT -22%. QDEL -14%. GNCA -9%. OCUL -9%. ACST -9%.Now read: Trillium Therapeutics (TRIL) Presents At Society For Neuro Oncology...

Premarket Gainers as of 9:05 am

Premarket Gainers as of 9:05 am By Seeking Alpha - Jul 26, 2017

TTPH +23% on positive late-stage data on antibiotic eravacycline.IRBT +18% on Q2 result.ETRM +18%.AMD +8% on Q2 result.X +7% on Q2 result.OCUL +7% on positive analyst action.HMNY +6% on the launch of...

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

OCUL Comments

Write your thoughts about Ocular Therapeutix Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Jatslo Oct 22, 2021 2:19PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

OCUL (P) 0.00000000 11.25000000

0 0

Roman Matějíček Dec 02, 2020 11:38AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Wow!

0 0

Roman Matějíček Mar 05, 2020 9:33AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Target?

0 0

Lindsay Apr 24, 2019 8:08AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Making a come back. Eye Think so!

1 0

JeffB Nov 30, 2018 11:25AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

$6.76 ... nice volume on extended move above 200-day SMA .... market participants must see an approval coming.

1 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="202966365">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="202966365" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="202966365">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="202966365">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	31,397.7	-482.5	-1.51%
	US 500	3,877.7	-96.1	-2.42%
	Dow Jones	31,392.24	-488.00	-1.53%
	S&P 500	3,877.40	-96.35	-2.42%
	Nasdaq	11,106.79	-428.49	-3.71%
	S&P 500 VIX	30.98	+2.50	+8.78%
	Dollar Index	101.850	-0.247	-0.24%

	Crude Oil WTI	110.69	+0.40	+0.36%
	Brent Oil	111.38	+0.60	+0.54%
	Natural Gas	8.923	+0.096	+1.09%
	Gold	1,863.57	+15.77	+0.85%
	Silver	22.047	+0.324	+1.49%
	Copper	4.2960	-0.0495	-1.14%
	US Soybeans	1,682.88	-3.12	-0.19%

	SPDR S&P 500	387.22	-9.70	-2.44%
	iShares Russell 2000	172.85	-5.36	-3.01%
	Invesco QQQ Trust	282.71	-10.77	-3.67%
	Direxion Daily Junior Gold Miners Bull 2X Shares	53.92	+1.61	+3.08%
	iShares Silver	20.35	+0.25	+1.24%
	ProShares Ultra VIX Short-Term Futures	16.77	+1.02	+6.51%
	ProShares UltraPro QQQ	25.57	-3.12	-10.88%

	Apple	137.91	-5.20	-3.63%
	Alphabet A	2,051.25	-178.51	-8.01%
	Tesla	633.45	-41.45	-6.14%
	Amazon.com	2,053.30	-97.85	-4.55%
	Netflix	177.42	-10.02	-5.35%
	Meta Platforms	176.74	-19.49	-9.93%
	Bank of America	35.04	-0.83	-2.32%

Recent Quotes

	Name	Price	Chg.	Chg. %
	OCUL	3.06	-0.21	-6.55%

	Name	Last	Chg. %	Vol.
	AMD	90.70	-4.60%	40.39M
	AAPL	137.90	-3.64%	33.90M
	FB	176.61	-10.00%	21.99M
	NVDA	159.49	-5.62%	19.64M
	TSLA	633.72	-6.10%	10.29M
	AMZN	2,057.20	-4.37%	2.20M
	GOOGL	2,050.19	-8.05%	1.90M

	Name	Last	Chg. %	Vol.
	NEM	68.98	+2.30%	1.47M
	ORLY	591.26	+2.10%	161.19K
	MCD	240.65	+1.11%	1.08M
	HSY	211.38	+1.02%	180.37K
	PM	103.91	+0.97%	768.04K
	K	69.07	+0.88%	452.43K
	BBY	73.05	+0.63%	7.31M

	Name	Last	Chg. %	Vol.
	FB	176.61	-10.00%	21.99M
	OMC	68.28	-9.99%	1.10M
	PDD	36.44	-9.91%	4.10M
	CCL	11.90	-9.25%	20.17M
	CZR	43.97	-8.87%	1.48M
	MELI	706.47	-8.76%	290.19K
	IPG	28.49	-8.72%	2.11M